CBRE Ansun BioPharma Michael Combs GlobeSt.com: What is driving this tremendous growth in life science investment? Michael Combs: GlobeSt.com: While life science investment grew, tech investment slowed. Why is there less venture capital interest in tech in San Diego? Combs: GlobeSt.com: The largest transactions were in the biotech and pharmaceutical industries. Is that typical? Combs: GlobeSt.com: How does this venture capital investment affect real estate? Combs: GlobeSt.com: Is industrial the asset classes that is most impacted by venture capital investment in life science? Combs:

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM Digital Member, you’ll receive:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Kelsi Maree Borland

Kelsi Maree Borland is a freelance journalist and magazine writer based in Los Angeles, California. For more than 5 years, she has extensively reported on the commercial real estate industry, covering major deals across all commercial asset classes, investment strategy and capital markets trends, market commentary, economic trends and new technologies disrupting and revolutionizing the industry. Her work appears daily on GlobeSt.com and regularly in Real Estate Forum Magazine. As a magazine writer, she covers lifestyle and travel trends. Her work has appeared in Angeleno, Los Angeles Magazine, Travel and Leisure and more.